HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hye Jung Kim Selected Research

Flavonoids

1/2019Nobiletin ameliorates hepatic ischemia and reperfusion injury through the activation of SIRT-1/FOXO3a-mediated autophagy and mitochondrial biogenesis.
11/2017Anthocyanins from the Fruit of Vitis Coignetiae Pulliat Inhibit TNF-Augmented Cancer Proliferation, Migration, and Invasion in A549 Cells
1/2016Morin, a Flavonoid from Moraceae, Inhibits Cancer Cell Adhesion to Endothelial Cells and EMT by Downregulating VCAM1 and Ncadherin.
10/2014Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hye Jung Kim Research Topics

Disease

57Neoplasms (Cancer)
02/2024 - 10/2006
39Breast Neoplasms (Breast Cancer)
08/2023 - 09/2008
24Inflammation (Inflammations)
05/2021 - 12/2007
19Neoplasm Metastasis (Metastasis)
03/2024 - 09/2008
16Ischemia
02/2023 - 02/2006
16Sepsis (Septicemia)
01/2018 - 07/2009
14Atherosclerosis
08/2021 - 03/2007
12Reperfusion Injury
12/2020 - 07/2006
9Myocardial Ischemia (Ischemic Heart Diseases)
01/2012 - 07/2006
8Infarction (Infarctions)
08/2009 - 01/2008
7Glioblastoma (Glioblastoma Multiforme)
09/2014 - 08/2008
6Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 12/2020
6Wounds and Injuries (Trauma)
07/2014 - 01/2006
5Necrosis
12/2021 - 04/2011
5Hypoxia (Hypoxemia)
10/2020 - 09/2007
4Body Weight (Weight, Body)
12/2021 - 08/2014
4Acute Kidney Injury (Acute Renal Failure)
12/2021 - 01/2018
4Insulin Resistance
05/2021 - 11/2009
4Fibrosis (Cirrhosis)
02/2021 - 11/2009
4Rectal Neoplasms (Rectal Cancer)
12/2017 - 06/2014
4Lung Neoplasms (Lung Cancer)
11/2017 - 05/2007
3Prostatic Neoplasms (Prostate Cancer)
02/2024 - 09/2013
3Endotoxemia
01/2023 - 02/2006
3Triple Negative Breast Neoplasms
12/2022 - 08/2021
3Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 01/2019
3Mouth Neoplasms (Oral Cancer)
09/2021 - 09/2008
3Diabetes Mellitus
08/2021 - 11/2009
3Stomach Neoplasms (Stomach Cancer)
03/2021 - 05/2009
3Carcinogenesis
05/2020 - 09/2008
3Hepatocellular Carcinoma (Hepatoma)
11/2014 - 10/2009
3Hypertension (High Blood Pressure)
09/2011 - 03/2008
2Ductal Carcinoma
08/2023 - 01/2018
2Pathologic Complete Response
12/2022 - 01/2019
2Parkinson Disease (Parkinson's Disease)
12/2022 - 11/2016
2Squamous Cell Carcinoma of Head and Neck
09/2021 - 02/2020
2Carcinoma (Carcinomatosis)
03/2021 - 09/2008

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
06/2023 - 04/2004
16HMGB1 Protein (HMG1)IBA
05/2018 - 07/2009
12CytokinesIBA
01/2022 - 07/2009
12Anthocyanins (Anthocyanin)IBA
03/2021 - 02/2006
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2016 - 02/2006
9PolyphenolsIBA
02/2024 - 12/2013
9NF-kappa B (NF-kB)IBA
11/2016 - 04/2004
8Adenosine Triphosphate (ATP)IBA
07/2020 - 07/2014
8Heme Oxygenase-1IBA
11/2017 - 07/2006
7Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
07/2016 - 09/2008
6Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
05/2019 - 07/2006
6YS 49IBA
03/2015 - 03/2008
5CollagenIBA
10/2020 - 06/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2020 - 11/2009
5AlkaloidsIBA
11/2017 - 01/2013
4Paclitaxel (Taxol)FDA LinkGeneric
02/2024 - 10/2008
4p38 Mitogen-Activated Protein KinasesIBA
06/2023 - 05/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2011
4EnzymesIBA
01/2021 - 08/2009
4InflammasomesIBA
12/2020 - 11/2018
4Cisplatin (Platino)FDA LinkGeneric
08/2020 - 05/2007
4Purinergic P2Y2 ReceptorsIBA
07/2020 - 04/2014
4Matrix Metalloproteinases (MMPs)IBA
05/2020 - 10/2009
4AntioxidantsIBA
01/2019 - 08/2009
4FlavonoidsIBA
01/2019 - 10/2014
4NucleotidesIBA
11/2018 - 08/2014
4Small Interfering RNA (siRNA)IBA
11/2018 - 10/2008
41,2,3,4-tetrahydroisoquinolineIBA
11/2017 - 01/2013
4LipopolysaccharidesIBA
11/2013 - 07/2009
3Indicators and Reagents (Reagents)IBA
08/2022 - 09/2008
3Triglycerides (Triacylglycerol)IBA
10/2021 - 11/2014
3CholesterolIBA
10/2021 - 10/2016
3LipidsIBA
10/2021 - 11/2009
3LigandsIBA
09/2021 - 07/2009
3Purinergic Receptors (Receptors, Purine)IBA
05/2021 - 05/2020
3Glucose (Dextrose)FDA LinkGeneric
12/2020 - 05/2012
3Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
10/2020 - 10/2014
3honokiolIBA
09/2020 - 10/2012
3higenamine (norcoclaurine)IBA
05/2012 - 02/2006
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2012 - 03/2007
3PPAR gammaIBA
12/2009 - 10/2006
3Oxidants (Oxidizing Agents)IBA
11/2007 - 01/2006
2beta-lapachoneIBA
12/2023 - 06/2023
2Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2023 - 06/2023
2ErbB Receptors (EGF Receptor)IBA
12/2022 - 03/2015
2Mebendazole (Anti-Worm)FDA Link
12/2022 - 08/2021
2Contrast MediaIBA
12/2021 - 12/2011
2Rosmarinic AcidIBA
10/2021 - 12/2020
2Biomarkers (Surrogate Marker)IBA
09/2021 - 05/2016
2Insulin (Novolin)FDA Link
05/2021 - 05/2016
2CateninsIBA
01/2021 - 04/2020
2EndotoxinsIBA
01/2021 - 05/2018
2oxidized low density lipoproteinIBA
12/2020 - 01/2019

Therapy/Procedure

12Radiotherapy
08/2023 - 10/2018
8Neoadjuvant Therapy
12/2022 - 12/2016
7Therapeutics
12/2023 - 01/2008
7Traditional Medicine (Folk Remedies)
05/2020 - 11/2013
6Ligation
10/2014 - 01/2008
6Punctures
10/2014 - 07/2009
4Drug Therapy (Chemotherapy)
03/2024 - 03/2014
4Mastectomy (Mammectomy)
11/2022 - 10/2010
3Chemoradiotherapy
12/2017 - 09/2015
2Segmental Mastectomy (Lumpectomy)
08/2023 - 01/2018
2Mammaplasty (Breast Reconstruction)
11/2022 - 04/2021